Deepu Madduri, MD
Deepu Madduri, MD, is Adjunct Assistant Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai and Senior Medical Director at Janssen Oncology. Dr. Madduri has expertise in plasma cell disorders including multiple myeloma, amyloid light-chain amyloidosis, POEMS syndrome, plasmacytoma, and monoclonal gammopathies of undetermined significance (MGUS).
Dr. Madduri’s research has included first-in-human/phase 1 clinical trial studies involving immunotherapy with checkpoint inhibitors and immune effector cells such as CAR T-cell therapy, NK-cell therapy, and Bi-specific antibodies. She has played an integral role in initiating CAR T-cell studies for multiple myeloma.
Dr. Madduri received her MD from the College of Medicine at the University of Oklahoma. She completed a residency in Internal Medicine at St. Mary Medical Center in Langhorne, Pennsylvania, and a fellowship in Hematology and Oncology at the University of California, Harbor Campus in Torrance, California, with additional fellowship training in Blood and Marrow Transplant at Stanford Hospital.